Application status and optimization suggestions of tumor organoids and CAR-T cell co-culture models
Abstract Tumor organoids, especially patient-derived organoids (PDOs) exhibit marked similarities in histopathological morphology, genomic alterations, and specific marker expression profiles to those of primary tumour tissues. They are applied in various fields including drug screening, gene editin...
Main Authors: | Rong-Xuan Ning, Cun-Yu Liu, Shi-Qi Wang, Wen-Kai Li, Xia Kong, Zhi-Wei He |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-024-03272-x |
Similar Items
-
CD19 CAR-expressing iPSC-derived NK cells effectively enhance migration and cytotoxicity into glioblastoma by targeting to the pericytes in tumor microenvironment
by: Dasom Kong, et al.
Published: (2024-05-01) -
Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells in vitro
by: Lei Yu, et al.
Published: (2021-01-01) -
Modeling nervous system tumors with human stem cells and organoids
by: Jie Duan, et al.
Published: (2023-03-01) -
Application of Organoids in Carcinogenesis Modeling and Tumor Vaccination
by: Zeyu Wang, et al.
Published: (2022-03-01) -
Standardization of organoid culture in cancer research
by: Changchun Zhou, et al.
Published: (2023-07-01)